AC
Armistice Capital Portfolio holdings
AUM
$2.64B
This Quarter Return
+7.03%
1 Year Return
+0.99%
3 Year Return
+16.29%
5 Year Return
+18.04%
10 Year Return
+34.8%
AUM
$3.77B
AUM Growth
+$3.77B
(+12%)
Cap. Flow
-$39.3M
Cap. Flow
% of AUM
-1.04%
Top 10 Holdings %
Top 10 Hldgs %
28.51%
Holding
375
New
122
Increased
57
Reduced
81
Closed
81
Top Buys
| 1 |
GSK
GSK
|
$70.8M |
| 2 |
Sanofi
SNY
|
$51.5M |
| 3 |
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
|
$50.9M |
| 4 |
argenx
ARGX
|
$44.9M |
| 5 |
Jazz Pharmaceuticals
JAZZ
|
$41.7M |
Top Sells
| 1 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$50.8M |
| 2 |
Incyte
INCY
|
$50.2M |
| 3 |
Keurig Dr Pepper
KDP
|
$45.5M |
| 4 |
UnitedHealth
UNH
|
$36.9M |
| 5 |
SentinelOne
S
|
$36.2M |
Sector Composition
| 1 | Healthcare | 68.31% |
| 2 | Consumer Staples | 10.4% |
| 3 | Consumer Discretionary | 9.57% |
| 4 | Technology | 7.34% |
| 5 | Communication Services | 2.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
PTC Therapeutics
PTCT
$3.92B
| $189M | 2.58% | 6,864,000 +714,000 | +12% | +$19.7M |
|
2
Neurocrine Biosciences
NBIX
$13.8B
| $138M | 1.89% | 1,048,000 -168,365 | -14% | -$22.2M |
|
3
Supernus Pharmaceuticals
SUPN
$2.53B
| $135M | 1.84% | 4,650,000 -442,000 | -9% | -$12.8M |
|
|
4
argenx
ARGX
$43.6B
| $121M | 1.65% | 318,000 +118,000 | +59% | +$44.9M |
|
5
Aurinia Pharmaceuticals
AUPH
$1.58B
| $85.7M | 1.17% | 9,536,000 +3,488,000 | +58% | +$31.4M |
|
|
DCPH
6
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $83.9M | 1.15% | 5,200,000 +588,000 | +13% | +$9.48M |
|
|
7
GSK
GSK
$79.9B
| $81.4M | 1.11% | 2,196,000 +1,911,000 | +671% | +$70.8M |
|
|
SWAV
8
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $81.2M | 1.11% | 426,057 +267,055 | +168% | +$50.9M |
|
|
9
Jazz Pharmaceuticals
JAZZ
$7.75B
| $80.1M | 1.09% | 651,626 +338,882 | +108% | +$41.7M |
|
10
Agios Pharmaceuticals
AGIO
$2.19B
| $78.5M | 1.07% | 3,524,000 +200,000 | +6% | +$4.45M |
|
11
Freshpet
FRPT
$2.72B
| $69.7M | 0.95% | 803,258 -11,471 | -1% | -$995K |
|
12
Alphabet (Google) Class A
GOOGL
$2.57T
| $69.3M | 0.95% | 496,000 +26,425 | +6% | +$3.69M |
|
13
Amazon
AMZN
$2.44T
| $68.9M | 0.94% | 453,292 -68,077 | -13% | -$10.3M |
|
|
NVRO
14
DELISTED
NEVRO CORP.
NVRO
| $68.3M | 0.93% | 3,176,000 -280,000 | -8% | -$6.03M |
|
15
Dentsply Sirona
XRAY
$2.85B
| $67.5M | 0.92% | 1,896,000 +68,195 | +4% | +$2.43M |
|
16
Travere Therapeutics
TVTX
$1.56B
| $66.4M | 0.91% | 7,384,000 -116,000 | -2% | -$1.04M |
|
17
Ironwood Pharmaceuticals
IRWD
$214M
| $65.2M | 0.89% | 5,700,000 +2,244,000 | +65% | +$25.7M |
|
18
Biohaven
BHVN
$1.63B
| $64.2M | 0.88% | 1,500,000 -536,000 | -26% | -$22.9M |
|
19
Microsoft
MSFT
$3.77T
| $60.9M | 0.83% | 161,993 +28,494 | +21% | +$10.7M |
|
20
Immunovant
IMVT
$2.56B
| $60.5M | 0.83% | 1,436,000 +400,123 | +39% | +$16.9M |
|
21
Exact Sciences
EXAS
$8.98B
| $57.1M | 0.78% | 771,821 +60,301 | +8% | +$4.46M |
|
22
Regeneron Pharmaceuticals
REGN
$61.5B
| $52.7M | 0.72% | 60,000 -14,998 | -20% | -$13.2M |
|
23
Biogen
BIIB
$19.4B
| $51.8M | 0.71% | 200,000 -76,788 | -28% | -$19.9M |
|
|
24
Sanofi
SNY
$121B
| $51.5M | 0.7% | +1,036,000 | New | +$51.5M |
|
25
Medtronic
MDT
$119B
| $50.1M | 0.68% | 608,000 -63,407 | -9% | -$5.22M |
|